Baneocin ointment d / nar approx. 250 IU + 5000 IU / g 20 g tube

Release form, composition and packaging

Ointment for external use is yellowish, homogeneous, with a weak characteristic odor.

1 g

bacitracin (in the form of bacitracin zinc) 250 IU

neomycin (as neomycin sulfate) 5000 IU

lanolin, white soft paraffin.

5 g - aluminum tubes (1) - cardboard packs.

20 g - aluminum tubes (1) - cardboard packs.

pharmachologic effect

Combined antibacterial drug for external use.

Contains two antibiotics that have a bactericidal effect, neomycin and bacitracin.

Bacitracin is a polypeptide antibiotic that inhibits the synthesis of the bacterial cell wall.

Bacitracin is active against gram-positive microorganisms such as beta-hemolytic streptococci, staphylococci, and some gram-negative pathogens.

Bacitracin resistance is extremely rare.

Neomycin is an aminoglycoside antibiotic that inhibits bacterial protein synthesis.

Active against gram-positive and gram-negative bacteria.

Through the use of a combination of these two antibiotics, a wide spectrum of action of the drug and synergism of action against a number of microorganisms, for example, staphylococci, are achieved.

Pharmacokinetics

The active ingredients, as a rule, are not absorbed (even by damaged skin), however, they are present in high concentrations in the skin.

Baneocin is well tolerated.

Tissue tolerance is considered excellent

inactivation by biological products, blood and tissue components is not observed.

If the drug is applied to large areas of skin lesions, the possibility of absorption of the drug and its consequences should be taken into account (see the sections Side effects", "Drug interactions", "Contraindications" and "Special instructions").

Indications for use

Treatment of infectious and inflammatory skin diseases caused by microorganisms sensitive to the drug:

- focal skin infections, incl.

boils, carbuncles (after surgery), staphylococcal sycosis, periporitis, deep folliculitis, purulent hydradenitis, paronychia

- bacterial skin infections of limited prevalence, incl.

contagious impetigo, infected ulcers of the lower extremities, secondarily infected eczema, secondary infection with dermatoses, cuts, abrasions, burns, cosmetic surgery and skin transplantation (also for prophylaxis and for dressing dressings).

Prevention and treatment of infection after surgery.

Baneocin ointment can be used as an additional treatment in the postoperative period.

Application of ointment to bandages is preferred for local treatment of patients with infected cavities and wounds (for example, bacterial infections of the external ear canal without perforation of the tympanic membrane, wounds or surgical incisions that heal by secondary intention).

Contraindications for use

- extensive skin lesions (the risk of developing an ototoxic effect, accompanied by hearing loss)

- severe disorders of excretory function due to heart or renal failure in patients with already existing lesions of the vestibular and cochlear systems in cases where absorption of the active components of the drug is possible

- infections of the external auditory canal with perforation of the tympanic membrane

- simultaneous use with antibiotics of the aminoglycoside group of systemic action (risk of cumulative toxicity)

- hypersensitivity to bacitracin, neomycin or to other aminoglycosides, auxiliary components of the drug.

Do not use this medicine to treat eye infections.

The drug should be prescribed with caution in patients with impaired liver and / or kidney function, acidosis, severe myasthenia gravis or other neuromuscular diseases.

Dosage regimen

The drug is used externally

Name ENG

BANEOCIN

Clinical and pharmacological group

Drug with antibacterial action for external use

ATX code

Other antibiotics for external use

Dosage

250IU / g + 5000IU / g x 20g

Structure

Active ingredients: zinc-bacitracin 250 IU, neomycin sulfate 5000 IU (5 mg).

Indications

Focal skin infections, for example: Furuncles, carbuncles (after surgery), scalp folliculitis, purulent hydrodenitis, pseudofurunculosis, paronychia

Bacterial skin infections of limited prevalence, for example: contagious impetigo, infected varicose ulcers, with secondary bacterial eczema, secondary infection with dermatoses, cuts, abrasions, burns, in cosmetic surgery and in skin transplantation (also for prophylactic use and under bandages).

After major and minor surgical procedures

Baneocin ointment can be used as an additional treatment in the postoperative period:

The application of Baneocin ointment to gauze strips is preferable for directed local treatment of patients with infected cavities and wounds (for example, infections of the external auditory canal, wounds or surgical incisions healing by secondary intention).

Contraindications

A history of hypersensitivity to bacitracin and / or neomycin, or to other aminoglycoside antibiotics.

Baneocin should not be used with significant skin lesions, since absorption of the drug can cause an ototoxic effect with hearing loss.

Baneocin should not be used in patients with severe disorders of excretory function, including renal etiology and already having lesions of the vestibular and cochlear systems, in cases where uncontrolled absorption of the drug is possible.

Do not use in the ear canal with perforation of the tympanic membrane.

Do not apply to eyes.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

INN / Active ingredient

neomycin (as sulfate), bacitracin (as zinc bacitracin)

Specifications

Scope of the drug

Leather

Release form

Ointment

Manufacturer country

Austria

Package quantity, pcs

one

Way of introduction

On the skin

Vacation conditions

Without recipe

Brand name

E. Merck

The amount of the dosage form in the primary package

20 g

Primary packaging type

Tuba

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Combined antibiotic

Dosage form

Ointment for external use

The target audience

Adult

Dosage (volume) of the substance in the preparation

zinc-bacitracin 250 IU, neomycin sulfate 5000 IU (5 mg)

Expiration date in days

1095

Package weight, g

thirty

Category

:

Antibiotics

,

Antiseptics and disinfectants

,

Disinfectants

Mode of application

:

Apply the required amount of ointment to the treatment site, if appropriate, under the bandage. < br> As a rule, in adults and children, Baneocin ointment is used two to three times a day. < br> When applied topically, the dose of neomycin should not exceed 1 g per day (corresponds to 200 g of powder or ointment) within 7 days.

With a repeated course, the maximum dose should be halved.

Anatomical and therapeutic characteristics

:

D06AX Other topical antibacterials

Information on technical characteristics, delivery set, country of manufacture "